Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Anesthesia|February 3, 2011
Epiglottic prolapse induced by lighted stylet tracheal intubationNaoyuki Ikegami, Aya Kikuchi, Sunao Tamai
Masui. the Japanese Journal of Anesthesiology|August 8, 2014
[Anesthesia for total hip arthroplasty in a patient with C1 inhibitor deficiency]Tomoko Oyaizu, Aya Kikuchi, Rie Minoshima, et al.
Bioorganic & Medicinal Chemistry|July 13, 2013
Discovery of 2-methyl-1-{1-[(5-methyl-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol: a novel, potent and selective type 5 17β-hydroxysteroid dehydrogenase inhibitorKazushi Watanabe, Akio Kakefuda, Minoru Yasuda, et al.
Biological & Pharmaceutical Bulletin|January 11, 2013
Pharmacological properties of FK886, a new, centrally active neurokinin-1 receptor antagonistTakako Yoshino-Furukawa, Yasue Maeda, Aya Kikuchi, et al.
Cancer Science|November 26, 2016
ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistanceAya Kikuchi, Tomoyuki Suzuki, Taisuke Nakazawa, et al.
Investigational New Drugs|July 2, 2014
In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3)Aya Kikuchi, Takashi Furutani, Hidenori Azami, et al.
Biological & Pharmaceutical Bulletin|June 4, 2013
Antiemetic effects of a potent and selective neurokinin-1 receptor antagonist, FK886, on cisplatin- and apomorphine-induced emesis in dogsTakako Yoshino Furukawa, Hiroe Nakayama, Aya Kikuchi, et al.
Bioorganic & Medicinal Chemistry|February 26, 2022
Discovery of ASP5878: Synthesis and structure-activity relationships of pyrimidine derivatives as pan-FGFRs inhibitors with improved metabolic stability and suppressed hERG channel inhibitory activityIkumi Kuriwaki, Minoru Kameda, Kazuhiko Iikubo, et al.
Molecular Cancer Therapeutics|March 26, 2025
Enhanced Antitumor Immunity by ASP1570, a Novel Diacylglycerol Kinase ζ Inhibitor, Offers a Potential Novel Immunotherapy for Treating CancerOsamu Ikeda, Aya Kikuchi, Hirofumi Tsuzuki, et al.
Pageof 1